# THIOTEPA
> **ANDA214222** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2021-03-08
## Drug
- **FDA Application Number:** ANDA214222
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** THIOTEPA
- **Generic name:** THIOTEPA
- **Active ingredients:** THIOTEPA
- **Dosage form:** POWDER
- **Route:** INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Dr.Reddy's Laboratories Inc.,
- **First approval:** 2021-03-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214222)
---
*MORVS · CC0 1.0*